Literature DB >> 6785783

Effects of levo-alpha-acetylmethadol (LAAM) on morphine self-administration in the rat.

S E Lukas, J E Moreton, N Khazan.   

Abstract

Rats bearing cerebrocortical electrodes for recording the electroencephalogram (EEG) were rendered tolerant to and physically dependent on morphine and subsequently trained to self-administer morphine (10 mg/kg injection) through a chronic intravenous cannula. Morphine was available for self-administration 24 h/day. Once morphine intake had stabilized (10-12 injections/day), levo-alpha-acetylmethadol (LAAM) was administered noncontingently via a chronic intragastric (IG) cannula as a single daily dose of either 1 or 4 mg/kg. These morphine self-administering rats were maintained on daily LAAM treatment for 12 consecutive days. Analysis of the patterns of lever pressing, morphine self-injections, and sleep-awake behavior revealed that daily IG administration of LAAM effectively suppressed morphine self-administration. The 1 mg/kg dose of LAAM reduced morphine intake by 30%-50%, while 4 mg/kg produced an 80%-90% decrease. The reduction in morphine self-administration occurred in the absence of overt signs of narcotic withdrawal, behavioral toxicity, or disruption of sleep-awake behavior in these rats. Termination of LAAM maintenance resulted in a gradual return of level pressing and morphine intake to pre-LAAM levels.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6785783     DOI: 10.1007/BF00431092

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  Imipramine-induced changes in the rapid eye movement sleep rebound and wet dog shakes of morphine-abstinent rats.

Authors:  B Colasanti; N Khazan
Journal:  Neuropharmacology       Date:  1975 May-Jun       Impact factor: 5.250

2.  Analgesic activity and toxic effects of acetylmethadol isomers in man.

Authors:  A S KEATS; H K BEECHER
Journal:  J Pharmacol Exp Ther       Date:  1952-06       Impact factor: 4.030

3.  Comparison of acetylmethadol and methadone in the treatment of long-term heroin users. A pilot study.

Authors:  J H Jaffe; C R Schuster; B B Smith; P H Blachley
Journal:  JAMA       Date:  1970-03-16       Impact factor: 56.272

4.  The metabolism of alpha-dl-acetylmethadol in the rat: the identification of the probable active metabolite.

Authors:  R E McMahon; H W Culp; F J Marshall
Journal:  J Pharmacol Exp Ther       Date:  1965-09       Impact factor: 4.030

5.  Methadone treatment of heroin addicts. Early results provide more questions than answers.

Authors:  W H Dobbs
Journal:  JAMA       Date:  1971-12-06       Impact factor: 56.272

6.  Discrete-trial choice procedure: effects of naloxone and methadone on choice between food and heroin.

Authors:  R R Griffiths; R M Wurster; J V Brady
Journal:  Pharmacol Rev       Date:  1975-09       Impact factor: 25.468

7.  Spontaneous vs. naloxone-induced abstinence in dependent rats self-administering L-alpha-acetylmethadol (LAAM) or morphine.

Authors:  G A Young; G F Steinfels; N Khazan
Journal:  Pharmacol Biochem Behav       Date:  1979-04       Impact factor: 3.533

8.  l-Acetylmethadol (LAM) treatment of opiate dependence: plasma and urine levels of two pharmacologically active metabolites.

Authors:  R E Billings; R E McMahon; D A Blake
Journal:  Life Sci       Date:  1974-04-16       Impact factor: 5.037

9.  Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats.

Authors:  J R WEEKS
Journal:  Science       Date:  1962-10-12       Impact factor: 47.728

10.  Head-shake distributions during self-maintained dependence on morphine, methadone, and l-alpha-acetylmethadol (LAAM) in the rat.

Authors:  S Chiba; G A Young; J E Moreton; N Khazan
Journal:  Psychopharmacology (Berl)       Date:  1977-08-31       Impact factor: 4.530

View more
  1 in total

1.  Self administration of cocaine in monkeys receiving LAAM acutely or chronically.

Authors:  Lisa R Gerak; Ruggero Galici; Charles P France
Journal:  Physiol Behav       Date:  2007-07-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.